0001209191-23-041351.txt : 20230705
0001209191-23-041351.hdr.sgml : 20230705
20230705201659
ACCESSION NUMBER: 0001209191-23-041351
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230703
FILED AS OF DATE: 20230705
DATE AS OF CHANGE: 20230705
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sandborn William J.
CENTRAL INDEX KEY: 0001923805
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40928
FILM NUMBER: 231071671
MAIL ADDRESS:
STREET 1: C/O VENTYX BIOSCIENCES, INC.
STREET 2: 662 ENCINITAS BLVD. STE 250
CITY: ENCINITAS
STATE: CA
ZIP: 92024
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ventyx Biosciences, Inc.
CENTRAL INDEX KEY: 0001851194
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 832996852
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 662 ENCINITAS BLVD., STE. 250
CITY: ENCINITAS
STATE: CA
ZIP: 92024
BUSINESS PHONE: (858) 945-2393
MAIL ADDRESS:
STREET 1: 662 ENCINITAS BLVD., STE. 250
CITY: ENCINITAS
STATE: CA
ZIP: 92024
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-07-03
0
0001851194
Ventyx Biosciences, Inc.
VTYX
0001923805
Sandborn William J.
C/O VENTYX BIOSCIENCES, INC.
662 ENCINITAS BLVD, SUITE 250
ENCINITAS
CA
92024
0
1
0
0
See Remarks
0
Common Stock
2023-07-03
4
M
0
11900
14.85
A
60289
D
Common Stock
2023-07-03
4
S
0
11900
40.0012
D
48389
D
Common Stock
2023-07-03
4
S
0
3487
40.00
D
27688
I
By Spouse
Stock Option (Right to Buy)
14.85
2023-07-03
4
M
0
11900
0.00
D
2032-05-09
Common Stock
11900
688100
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 19, 2022.
Represents the weighted average share price of an aggregate total of 11,900 shares sold in the price range of $40.00 to $40.04. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person's spouse on December 19, 2022.
Represents the weighted average share price of an aggregate total of 3,487 shares sold in the price range of $40.00 to $40.02. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the shares subject to the option will vest on the one year anniversary of the Vesting Commencement Date (as defined below), and 1/48th of the shares subject to the option will vest ratably each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean May 9, 2022.
President and Chief Medical Officer
/s/ Christopher Krueger, as Attorney-in-Fact
2023-07-05